PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,720 Cr | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr | ₹2,910 Cr |
What is the latest Total Debt ratio of PIRAMAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4,720 Cr |
| Mar2024 | ₹4,559 Cr |
| Mar2023 | ₹5,505 Cr |
| Mar2022 | ₹4,023 Cr |
| Mar2021 | ₹2,910 Cr |
How is Total Debt of PIRAMAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,720 Cr | 3.54 | |
| Mar2024 | ₹4,559 Cr | -17.18 | |
| Mar2023 | ₹5,505 Cr | 36.82 | |
| Mar2022 | ₹4,023 Cr | 38.25 | |
| Mar2021 | ₹2,910 Cr | - | |
Compare Total Debt of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,287.1 Cr | -2.2% | 13.5% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,830.0 Cr | 5.9% | -0.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.5% | 8.7% | 3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,166.0 Cr | 2% | -1.6% | 25.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | -0.2% | 2.2% | 12.8% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 0.8% | 5.9% | -15.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.2% |
13.5% |
-25.3% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses